Marquet Magda
SEC Form 4 insider trading activity
Marquet Magda has filed 3 SEC Form 4 filings (5 transaction rows) across 3 companies, including TRAX, IMMX, ANAB, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jun 17, 2026.
On the most recent filing, Marquet Magda is listed as Director at ANAPTYSBIO, INC. Inside the rolling window, Marquet Magda reported no open-market purchases and 1 open-market sale totaling $531K in ANAB.
Companies traded
Other insiders at TRAX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$531K
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Marquet Magda made?
Marquet Magda has filed 3 SEC Form 4 filings (5 transaction rows) across 3 companies, including TRAX, IMMX, ANAB since 2026.
Which companies does Marquet Magda trade?
Marquet Magda has filed SEC Form 4 disclosures for 3 companies, including TRAX, IMMX, ANAB.
When was Marquet Magda's most recent SEC Form 4 filing?
Marquet Magda's most recent SEC Form 4 filing on Tracefour is dated Jun 17, 2026.
What is Marquet Magda's total buy and sell value in the current window?
Inside the rolling retention window, Marquet Magda bought $0 and sold $531K based on SEC Form 4 filings.
What was Marquet Magda's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 11,000 ANAB shares on 2026-01-15, worth $531K, per SEC Form 4 filings.